SPRB Earnings

Quarterly EPS
$-15.75
Q3 2024
$-42.59
Q4 2024
$-23.95
Q1 2025
$-3.50
Q2 2025
$-14.58
Q3 2025
$-11.04
Q4 2025
$-8.94
Q1 2026
$-6.68
Q2 2026
Latest RevenueN/A
Latest Net Income-16229000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$6.680-16229000-90.9%
Q1 2026-$8.940-12266000+62.7%
Q4 2025-$11.040-14646000-100.0%+74.1%
Q3 2025-$14.580-8212000-100.0%+7.4%
Q2 2025-$3.500-2067000-100.0%+79.1%
Q1 2025-$23.950-14041000-100.0%-14.0%
Q4 2024-$42.59697.0K-23559000-75.9%-133.4%
Q3 2024-$15.75602.0K-8671000-80.4%+30.0%
Q2 2024-$16.731.6M-9181000
Q1 2024-$21.002.0M-11625000
Q4 2023-$18.252.9M-9950000
Q3 2023-$22.503.1M-12354000
Spruce Biosciences (SPRB) — Earnings